Copper, zinc, and selenium in human blood and urine after injection of sodium 2,3-dimercaptopropane-1-sulfonate: A study on subjects with dental amalgam

Biological Trace Element Research

Volumn 91, Issue 1, 2003, Pages 19-31

  Høl, Paul Johan ^a   Vamnes, Jan Sverre ^a   Gjerdet, Nils Roar ^a   Eide, Rune ^a   Isrenn, Rolf ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Blood; Chelating agents; Copper; Dental amalgam; DMPS; Excretion; Selenium; Urine; Zinc

Indexed keywords

COPPER; DENTAL ALLOY; RINGER ACETATE; SELENIUM; UNITHIOL; ZINC;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; COPPER BLOOD LEVEL; EXCRETION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; URINE LEVEL; ZINC BLOOD LEVEL; ZINC URINE LEVEL;

ADULT; ALGORITHMS; CHELATING AGENTS; COPPER; CREATININE; DENTAL AMALGAM; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; REFERENCE STANDARDS; SELENIUM; SPECTROPHOTOMETRY, ATOMIC; UNITHIOL; ZINC;

EID: 0037275839     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:91:1:19     Document Type: Article

References (37)

1. R. M. Maiorino, R. C. Dart, D. E. Carter, and H. V. Aposhian, Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans, J. Pharmacol. Exp. Ther. 259, 808-814 (1991).
2. S. Waelti, Pharmakokinetik der uroprotektiven Sulfhydrylgruppen in Urin gesunder Probanden nach peroraler Verabreichung von Na-mercaptoethansulfonat (Uromexitan) und von Na-Dimercaptopropansulfonat (Dimaval), dissertation thesis, Universität Bern (1992).
3. B. Gabard and R. Walser, Note on the metabolism of the mercury chelating agent sodium 2,3-dimercaptopropane-1-sulfonate, J. Toxicol. Environ. Health 5, 759-764 (1979).
4. H. V. Aposhian, DMSA and DMPS-water soluble antidotes for heavy metal poisoning, Annu. Rev. Pharmacol. Toxicol. 23, 193-215 (1983).
5. H. V. Aposhian, R. M. Maiorino, M. Rivera, D. C. Bruce, R. C. Dart, K. M. Hurlbut, et al., Human studies with the chelating agents, DMPS and DMSA, J. Toxicol. Clin. Toxicol. 30, 505-528 (1992).
6. J. J. Chisolm, BAL, EDTA, DMSA and DMPS in treatment of lead poisoning in children, J. Toxicol. Clin. Toxicol. 30, 493-504 (1992).
7. J. Aaseth, D. Jacobsen, O. Andersen, and E. Wickstrøm, Treatment of mercury and lead poisonings with dimercaptosuccinic acid and sodium dimercaptopropanesulfonate-a review, Analyst 120, 853-854 (1995).
8. K. M. Hurlbut, R. M. Maiorino, M. Mayersohn, R. C. Dart, D. C. Bruce, and H. V. Aposhian, Dertermination and metabolism of dithiol chelating-agents XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers, J. Pharmacol. Exp. Ther. 268, 662-668 (1994).
9. R. M. Maiorino, Z. F. Xu, and H. V. Aposhian, Determination and metabolism of dithiol chelating agents. XVII. In humans, sodium 2,3-dimercapto-1-propanesulfonate is bound to plasma albumin via mixed disulfide formation and is found in the urine as cyclic polymeric disulfides, J. Pharmacol. Exp. Ther. 277, 375-384 (1996).
10. World Health Organization (WHO), Environmental Health Criteria 118, WHO, Geneva (1991).
11. F. L. Lorscheider, M. J. Vimy, and A. O. Summers, Mercury exposure from silver tooth fillings-emerging evidence questions a traditional paradigm, FASEB J. 9, 504-508 (1995).
12. T. W. Clarkson, The toxicology of mercury, Crit. Rev. Clin. Lab. Sci. 34, 369-403 (1997).
13. J. S. Vamnes, R. Eide, R. Isrenn, P. J. Høl, and N. R. Gjerdet, Diagnostic value of a Chelating Agent in patients with symptoms allegedly caused by amalgam fillings, J. Dent. Res. 79, 868-874 (2000).
14. O. Torres-Alanis, L. Garza-Ocanas, M. A. Bernal, and A. Pineyro-Lopez, Urinary excretion of trace elements in humans after sodium 2,3-dimercaptopropane-1-sulfonate challenge test, J. Toxicol. Clin. Toxicol. 38, 697-700 (2000).
15. G. Sällsten, L. Barregård, and A. Schütz, Clearance half-life of mercury in urine after the cessation of long term occupational exposure - influence of a chelating agent (DMPS) on excretion of mercury in urine, Occup. Environ. Med. 51, 337-342 (1994).
16. J. M. McCord and I. Fridovich, The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen, J. Biol. Chem. 244, 6049-6055 (1969).
17. L. Flohe, W. A. Gunzler, and H. H. Schock, Glutathione peroxidase: a selenoenzyme., FEBS Lett. 32, 132-134 (1973).
18. J. T. Rotruch, Discovery of the role of selenium in glutathione peroxidase, in Selenium in Biology and Medicine, J. Spallholz, J. L. Martin, and H. E. Ganther, eds., AVi, Westport, CT, pp. 10-16 (1981).
19. A. T. Diplock, The role of vitamine E and selenium in the prevention of oxygen-induced tissue damage, in Selenium in Biology and Medicine, J. E. Spallholz, J. L. Martin, and H. E. Ganther, eds., AVi, Westport, CT, pp. 303-316 (1981).
20. P. J. Høl, J. S. Vamnes, N. R. Gjerdet, R. Eide, and R. Isrenn, Dental amalgam and selenium in blood, Environ. Res. 87, 141-146 (2001).
21. P. J. Høl, J. S. Vamnes, N. R. Gjerdet, R. Eide, and R. Isrenn, Dental amalgam affects urinary selenium excretion, Biol. Trace Element Res. 85, 137-147 (2002).
22. J. Ruprecht, Dimaval (DMPS)-Summary of Scientific Literature, Scientific Monograph, Heyl Chem. pharm. Fabrik, Berlin, Germany (1993).
23. J. J. Chisolm, Jr. and D. J. Thomas, Use of 2,3-dimercaptopropane-1-sulfonate in treatment of lead poisoning in children, J. Pharmacol. Exp. Ther. 235, 665-669 (1985).
24. B. Guldager, P. J. Jørgensen, and P. Grandjean, Metal excretion and magnesium retention in patients with intermittent claudication treated with intravenous disodium EDTA, Clin. Chem. 42, 1938-1942 (1996).
25. A. E. Martell and R. M. Smith, Critical Stability Constants, Plenum, New York, Vol. 4 (1976).
26. J. Ruprecht, Dimaval (DMPS), Scientific Monograph, Heyl Chem. pharm. Fabrik, Berlin, Germany (1997).
27. L. K. Dubinina, M. A. Sheikkh, K. K. Ospanov, and L. N. Germanova, Physicochemical analysis of the interaction between zinc and cadmium ions and unithiol in aqueoussolutions, Russ. J. Coord. Chem. 21, 23-25 (1995).
28. J. R. Stewart and G. L. Diamond, In vivo renal tubular secretion and metabolism of the disulfide of 2,3- dimercaptopropane-1-sulfonate, Drug Metab. Dispos. 16, 189-195 (1988).
29. F. Islinger, M. Gekle, and S. H. Wright, Interaction of 2,3-dimercapto-1-propane sulfonate with the human organic anion transporter hOAT1, J. Pharmacol. Exp. Ther. 299, 741-747 (2001).
30. D. Brune, N. R. Gjerdet, and G. Paulsen, Gastrointestinal and in vitro release of copper, cadmium, indium, mercury and zinc from conventional and copper-rich amalgams, Scand. J. Dent. Res. 91, 66-71 (1983).
31. N. R. Gjerdet and M. Berge, Liberation of copper, zinc, and cadmium from different amalgams, Acta Odontol. Scand. 41, 217-220 (1983).
32. M. Blanusa, L. Prester, S. Radic, and B. Kargacin, Inorganic mercury exposure, mercury-copper interaction, and DMPS treatment in rats, Environ. Health Perspect. 102, 305-307 (1994).
33. K. T. Suzuki, C. Sasakura, and S. Yoneda, Binding sites for the (Hg-Se) complex on selenoprotein P, Biochim. Biophys. Acta 1429, 102-112 (1998).
34. J. J. R. F. d. Silva and R. J. P. Williams, The Biological Chemistry of the Elements. The Inorganic Chemistry of Life, 2nd ed., Oxford University Press, New York (2001).
35. H. A. Schroeder, D. V. Frost, and J. J. Balassa, Essential trace metals in man: selenium, J. Chronic Dis. 23, 227-243 (1970).
36. D. Vitoux, J. Arnaud, and P. Chappuis, Are copper, zinc and selenium in erythrocytes valuable biological indexes of nutrition and pathology? J. Trace Elements Med. Biol. 13, 113-128 (1999).
37. M.C. Linder, L. Wooten, P. Cerveza, S. Cotton, R. Shulze, and N. Lomeli, Copper transport, Am. J. Clin. Nutr. 67, 965S-971S. (1998).